Cheung, L., Wu, S., Hodkinson, B., Tam, C., Wierda, W., Ghia, P., Szoke, A., Glusman, E. S. (2025). First-line ibrutinib + venetoclax shows benefit across genomic subgroups in patients with chronic lymphocytic leukemia (CLL): Results from Phase 2 captivate study and Phase 3 glow study. Blood. https://doi.org/10.1182/blood-2025-5672